Rapamycin formulations for oral administration
US5536729A · kind A · utility
91Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 1994 |
| Grant date | Jul 16, 1996 |
| Priority date | — |
| Expiry date | Sep 9, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel oral rapamycin formulations which have, per 100 ml of the formulation, from about 0.01 grams to about 5.0 grams of rapamycin, from about 0.05% to about 10% by volume of surfactant, and from about 75% to about 99.95% by volume of a solution of phospholipid or lecithin in which the phospholipid or lecithin therein is 40% to 75% by weight.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.